Praram 9 Hospital PCLBKK:PR9 +2.27%89 EBITDA Margin % is 24.60% as of Mar. 2026, which is 23% above its 10-year median of 19.99. GuruFocus rates BKK:PR9 with a GF Score™ of 89/100 and a GF Value™ of ฿23.58 (Modestly Undervalued). Among 665 Healthcare Providers & Services companies, Praram 9 Hospital PCL ranks better than 84.06% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Praram 9 Hospital PCL EBITDA Margin % Related Terms
Praram 9 Hospital PCL EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Praram 9 Hospital PCL's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:PR9 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Praram 9 Hospital PCL's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Praram 9 Hospital PCL EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Praram 9 Hospital PCL's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Praram 9 Hospital PCL's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Praram 9 Hospital PCL (BKK:PR9) has a EBITDA Margin % of 24.60% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Praram 9 Hospital PCL and its competitors. This is 23% above median its historical median of 19.99. Over the past decade, Praram 9 Hospital PCL's EBITDA Margin % has ranged from 13.23 to 25.22. According to the industry distribution chart, Praram 9 Hospital PCL ranks #106 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 15.9%.
Is Praram 9 Hospital PCL's EBITDA Margin % too high?
Praram 9 Hospital PCL's current EBITDA Margin % of 24.60% is 23% above median its 10-year median of 19.99. Over the past 10 years, this metric has ranged from a low of 13.23 to a high of 25.22. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Praram 9 Hospital PCL's value of 24.60% is 140.2% above this industry median. Based on the distribution chart, Praram 9 Hospital PCL ranks #106 out of 665 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Praram 9 Hospital PCL has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Praram 9 Hospital PCL's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Praram 9 Hospital PCL ranks #106 out of 665 companies for EBITDA Margin %. This places Praram 9 Hospital PCL in the top 16% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.24. Praram 9 Hospital PCL's value of 24.60% is 140.2% above this benchmark. Historically, Praram 9 Hospital PCL's own EBITDA Margin % has ranged from 13.23 to 25.22 over the past decade. While the company's 10-year median is 19.99 vs. the industry median of 10.24, Praram 9 Hospital PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Praram 9 Hospital PCL's current EBITDA Margin % of 24.60% is 140.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Praram 9 Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Praram 9 Hospital PCL's current EBITDA Margin % is 24.60%, which is 23% above median its own 10-year median of 19.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Praram 9 Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, Praram 9 Hospital PCL (BKK:PR9) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿23.58, compared to a current price of ฿18.00 — trading 23.7% below its estimated fair value. The current EBITDA Margin % is 24.60%, which is 23% above median its 10-year median of 19.99 and 140.2% above the Healthcare Providers & Services industry median of 10.24. Praram 9 Hospital PCL's overall GF Score™ is 89/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Praram 9 Hospital PCL (BKK:PR9), the current EBITDA Margin % is 24.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Praram 9 Hospital PCL (BKK:PR9) Overvalued in 2026?
Based on GuruFocus' analysis, Praram 9 Hospital PCL stock appears to be undervalued.
The current stock price of ฿18.00 is trading 23.7% below its estimated GF Value™ of ฿23.58.
GuruFocus considers Praram 9 Hospital PCL to be Modestly Undervalued.
Key valuation signals for BKK:PR9:
EBITDA Margin %: 24.60% (23% above median its 10-year median of 19.99)
GF Value™: ฿23.58 vs. price of ฿18.00 (23.7% below fair value)
Industry Position: 140.2% above the Healthcare Providers & Services median (#106 of 665)
No single metric tells the full story. See the BKK:PR9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Praram 9 Hospital PCL is engaged in hospital operations in Bangkok. The company operates an overnight general hospital under the name of Praram 9 Hospital. The revenue derived from hospital operations mainly consists of medical fees, hospital room sales, and medicine sales. Geographically, the company operates only in Thailand.
89GF Score
Get the complete analysis for BKK:PR9
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:PR9 has been successfully added to your 
